Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Holdings Inc. demonstrated robust financial performance with a notable revenue growth of 25.6% year-over-year in the Private Duty Services segment, totaling $514.4 million, significantly surpassing expectations. The Home Health & Hospice segment also contributed positively, reporting a 15.3% increase in revenue to $62.4 million, driven by strong admissions growth. Additionally, the company raised its revenue guidance to over $2.375 billion, indicating a confident outlook and improved financial flexibility as cash flow metrics surpassed prior estimates.

Bears say

Aveanna Healthcare Holdings Inc. faces multiple fundamental challenges that contribute to a negative outlook on its stock. Key concerns include potential reimbursement pressures, high leverage, regulatory issues, and increased competition, all of which could hinder the company's organic growth and ability to integrate acquisitions effectively. Additionally, labor headwinds and a decline in gross margins, coupled with a disappointing revenue growth of only 0.5% year-over-year, indicate that the company may struggle to meet its financial targets in the near term.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.19, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.19, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.